Publication:
XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.

No Thumbnail Available
Date
2013-01-01T00:00:00Z
Authors
UYGUN, K
BILICI, A
KAYA, S
Oven, Ustaalioglu
YILDIZ, R
TEMIZ, S
Seker, MESUT
AKSU, G
CABUK, D
GUMUS, M
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Description
Keywords
Citation
UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., Seker M., AKSU G., CABUK D., GUMUS M., -XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.-, Asian Pacific journal of cancer prevention : APJCP, cilt.14, ss.2283-8, 2013
Collections
Page Views

0

File Downloads

0

Sustainable Development Goals